It’s a move that could severely limit the number of people taking the controversial new Alzheimer’s drug Aduhelm: Medicare on Tuesday proposed to only cover the cost of the pricey medication for people enrolled in approved clinical trials. A final decision on coverage is expected later this year. The drug costs $28,200 per year, but… read on > read on >
Swapping out the butter or other artery-clogging fats in your diet for heart-healthy olive oil may add years to your life, researchers say. Folks who consume more than 1/2 a tablespoon of olive oil a day are less likely to die from heart disease, cancer, neurodegenerative diseases like Alzheimer’s or lung disease when compared to… read on > read on >
Examining a woman’s health in midlife can predict her health decades later, researchers say. Four specific factors — higher body mass index (BMI), smoking, arthritis and depressive symptoms — at age 55 are associated with clinically important declines in physical health 10 years later, a new study reports. “Age 55 to 65 may be a… read on > read on >
Medicare has been told to reassess a significant premium increase it had announced that largely stemmed from the expensive new Alzheimer’s drug Aduhelm. U.S. Health and Human Services Secretary Xavier Becerra’s directive, which was announced on Monday, comes shortly after Aduhelm maker Biogen cut the price of the drug by about half, from $56,000 to… read on > read on >
Swabs that come with at-home rapid antigen COVID-19 tests should be used in the nose and not the throat, the U.S. Food and Drug Administration warns. It issued the warning on Twitter in response to reports that some people are using swabs intended for nasal samples to take samples from their throats and posting their… read on > read on >
For people newly diagnosed with advanced melanoma, a combination of two immunotherapy drugs can double the amount of time their cancer remains progression-free, a clinical trial has found. The treatment combines two drugs known as immune checkpoint inhibitors. One, called nivolumab (Opdivo), is already standard for advanced melanoma; the other, relatlimab, is not yet approved.… read on > read on >
Eat right to protect your sight. That’s the advice of the Glaucoma Research Foundation, which offers its recipe for healthier eyes. Glaucoma is group of eye diseases that cause progressive vision loss through damage to the optic nerve. It is the second-leading cause of blindness. As with other health issues, good nutrition can make a… read on > read on >
Citing the rapid spread of the Omicron variant and the need for protection against it, U.S. federal health officials are shortening the recommended time between the second dose of the Moderna vaccine and a booster shot from six months down to five. “The country is in the middle of a wave of the highly contagious… read on > read on >
Following a months-long and unprecedented review, Medicare officials expect to announce within the next couple of weeks whether the program will cover the controversial Alzheimer’s drug Aduhelm. The drug’s benefits are in question and its annual price tag tops $28,000. The U.S. Centers for Medicare and Medicaid Services (CMS) tend to cover with little fanfare… read on > read on >
First, there was Beyond Meat. Next up? Beyond Fried Chicken. KFC announced Wednesday that it will begin offering a plant-based chicken in some of its meals on Jan. 10, from the same company known for its meat-free burgers, Beyond Meat. Beyond Fried Chicken was developed by Beyond Meat exclusively for KFC, according to a news… read on > read on >
